Trials / Completed
CompletedNCT03660436
An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants
An Open-label, Single-sequence Study to Investigate the Effects of BMS-986165 at Steady State on the Single Dose Pharmacokinetics of Mycophenolate Mofetil (MMF) in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 131 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the effects of experimental medication BMS-986165 in healthy male participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986165 | Specified dose on specified days |
| DRUG | MMF | Specified dose on specified days |
Timeline
- Start date
- 2018-08-14
- Primary completion
- 2018-10-10
- Completion
- 2018-10-18
- First posted
- 2018-09-06
- Last updated
- 2018-12-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03660436. Inclusion in this directory is not an endorsement.